Elena Mikhaylovna Frantsiyants
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena Mikhaylovna Frantsiyants has a total of 499 co-authors. Here are the top co-authors by number of shared publications:
- Valeriya Akhtyamovna Bandovkina
National Medical Research Center of Oncology, Ministry of Health of Russia
88 shared publications - Irina Viktorovna Kaplieva
Rostov Research Institute of Oncology
83 shared publications - Irina Valer'EVna Neskubina
National Medical Research Center of Oncology, Ministry of Health of Russia
80 shared publications - Ekaterina Igorevna Surikova
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
75 shared publications - Lidiya Konstantinovna Trepitaki
National Medical Research Center for Oncology, Ministry of Health of Russia
57 shared publications - Natal'YA Dmitrievna Cheryarina
National Medical Research Center of Oncology, Ministry of Health of Russia
51 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Adrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Open AccessAdrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- Open Access
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Adrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- 1 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 15,p. 8-13
Open AccessAdrenal hormonal dysfunction in adolescents with acute lymphoblastic leukemia during chemotherapy
Objective . To evaluate the levels of hypothalamic–pituitary–adrenal (HPA) axis hormones, including adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in adolescents with acute lymphoblastic leukemia (ALL) at different stages of chemotherapy. Materials and methods . The study was conducted from 2023 to 2025 and included adolescents of both sexes with ALL (n=40). Serum levels of ACTH, cortisol, and DHEA-S were measured by enzyme-linked immunosorbent assay (ELISA) before treatment initiation and after completion of consolidation phase III. Hormonal values obtained in apparently healthy adolescents (n=40) were used as reference values. Statistical analysis was performed using Statistica 10 software. Results . Before treatment, boys with ALL (n=20) had ACTH levels 1.7-fold lower than the reference values. Cortisol levels were 4.8-fold higher than normal in 25 % (n=5) of cases and 7.0-fold lower than normal in 50% (n=10). DHEA-S levels decreased 2.4-fold in all patients, while the cortisol/DHEA-S ratio was 11-fold higher than normal in 30 % (n=6) and 3.9-fold lower than normal in 35 % (n=7). After completion of consolidation phase III, ACTH levels were 1.3-fold higher than the reference values; cortisol remained 5.5-fold below normal in 15% (n=3), whereas DHEA-S remained 5.5-fold lower than normal in 65% (n=13). The cortisol/DHEA-S ratio was 4.3-fold above normal in 50% (n=10) and 1.5-fold below normal in the remaining 50% (n=10). In girls with ALL (n=20), before treatment cortisol levels were 5.5-fold lower than normal in 30% (n=6). ACTH and DHEA-S levels were 1.8-fold and 27.0-fold lower than the reference values, respectively, while the cortisol/DHEA-S ratio was 19-fold higher than normal. After completion of consolidation phase III, cortisol levels were 3.7-fold below normal in 20% (n=4). DHEA-S remained decreased in 35% (n=7) and 65% (n=13) of patients by 1.4-fold and 4.0-fold, respectively. The cortisol/DHEA-S ratio exceeded the reference values by 1.5- to 10.5-fold. Conclusion . The development of ALL is associated with disturbances in HPA axis hormone levels. Chemotherapy does not result in their complete normalization, which justifies dynamic monitoring through close collaboration between the pediatric oncologist and the endocrinologist.
- Open Access
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 49-66
Morphological characteristics of An3Ca endometrioid carcinoma and visceral organs in female nude mice with experimental diabetes mellitus
Purpose of the study . To investigate the morphological features of induced An3Ca endometrioid carcinoma and visceral organs in BALB/c nude mice under conditions of diabetes mellitus. Materials and methods . Female BALB/c nude mice weighing 25 ± 2.5 g were used to model uterine tumor growth under conditions of diabetes mellitus. The animals were divided into two experimental groups: group 1 (control) – intrauterine growth of endometrioid carcinoma (n = 5); group 2 (study group) – intrauterine growth of endometrioid carcinoma in the presence of diabetes mellitus (n = 5). Sections of the tumor nodules and organs (uterus, ovaries, liver, lungs, thyroid gland, adrenal glands, and pancreas) were examined microscopically, with images captured using a digital camera. Results . Tumor growth without alloxan administration resulted in the formation of a single tumor nodule in the right uterine horn, with preservation of the main morphological features of its architecture. In contrast, alloxan administration was associated with the formation of a tumor consisting of several separate nodules that completely obliterated the structure of the right ovary and replaced it with tumor tissue. Metastatic involvement of the liver accompanied by vascular congestion of the parenchyma was observed. In the lungs, destruction of the alveolar and bronchial structures was accompanied by vascular congestion, foci of hemorrhage, mucus accumulation in the airway lumens, and the presence of tumor cells. Marked thickening of the colloid was observed throughout the thyroid follicles. Involutional changes were noted in the X-zone and zona glomerulosa of the adrenal cortex, with focal expansion of the zona fasciculata. Diabetes modeling resulted in almost complete loss of the exocrine pancreatic parenchyma, exposing the stromal framework of the organ. Its morphological identity could be established only from isolated small areas of degeneratively altered acini and rare remnants of the islets of Langerhans. Conclusion . In the experimental bimodal model combining two pathological processes, cancer and diabetes mellitus, morphological evidence of mutually reinforcing mechanisms of adverse systemic effects involving multiple organs was observed. This pronounced synergistic effect was manifested by stimulation of tumor progression and pathological changes in visceral organs, expanding our understanding of cancer pathogenesis in the presence of comorbid disease.
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 49-66
Open AccessMorphological characteristics of An3Ca endometrioid carcinoma and visceral organs in female nude mice with experimental diabetes mellitus
Purpose of the study . To investigate the morphological features of induced An3Ca endometrioid carcinoma and visceral organs in BALB/c nude mice under conditions of diabetes mellitus. Materials and methods . Female BALB/c nude mice weighing 25 ± 2.5 g were used to model uterine tumor growth under conditions of diabetes mellitus. The animals were divided into two experimental groups: group 1 (control) – intrauterine growth of endometrioid carcinoma (n = 5); group 2 (study group) – intrauterine growth of endometrioid carcinoma in the presence of diabetes mellitus (n = 5). Sections of the tumor nodules and organs (uterus, ovaries, liver, lungs, thyroid gland, adrenal glands, and pancreas) were examined microscopically, with images captured using a digital camera. Results . Tumor growth without alloxan administration resulted in the formation of a single tumor nodule in the right uterine horn, with preservation of the main morphological features of its architecture. In contrast, alloxan administration was associated with the formation of a tumor consisting of several separate nodules that completely obliterated the structure of the right ovary and replaced it with tumor tissue. Metastatic involvement of the liver accompanied by vascular congestion of the parenchyma was observed. In the lungs, destruction of the alveolar and bronchial structures was accompanied by vascular congestion, foci of hemorrhage, mucus accumulation in the airway lumens, and the presence of tumor cells. Marked thickening of the colloid was observed throughout the thyroid follicles. Involutional changes were noted in the X-zone and zona glomerulosa of the adrenal cortex, with focal expansion of the zona fasciculata. Diabetes modeling resulted in almost complete loss of the exocrine pancreatic parenchyma, exposing the stromal framework of the organ. Its morphological identity could be established only from isolated small areas of degeneratively altered acini and rare remnants of the islets of Langerhans. Conclusion . In the experimental bimodal model combining two pathological processes, cancer and diabetes mellitus, morphological evidence of mutually reinforcing mechanisms of adverse systemic effects involving multiple organs was observed. This pronounced synergistic effect was manifested by stimulation of tumor progression and pathological changes in visceral organs, expanding our understanding of cancer pathogenesis in the presence of comorbid disease.
- Open Access
- 18 September 2026
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 13 (3) , 8-19
The genes copy number variation features in blood plasma of uterine cancer patients and disease prognosis
Introduction. Uterine cancer is a leading gynecologic oncology morbidity. Early prediction of metastatic disease is critical for treatment decisions. Therefore, the search for minimally invasive molecular markers for predicting metastasis is a pressing issue. Promising biomarkers in this regard include gene copy number values in circulating cell-free DNA (cfDNA) in plasma. Aim. To analyze the relative copy number of genes regulating mitochondrial function in plasma of uterine cancer patients to develop a minimally invasive method for predicting metastasis. Materials and methods. The bioinformatics phase of the study identified a list of genes associated with mitochondrial dysfunction and abnormal copy number in uterine cancer. The study included 98 patients diagnosed with adenocarcinoma of the corpus uteri (G1 (n = 43), G2 (n = 35) and G3 (n = 20)), 15 patients with uterine myoma and 20 conditionally healthy donors. The relative copy number of 13 genes was determined by quantitative real-time polymerase chain reaction on cfDNA samples from blood plasma. ROC analysis and LASSO-penalized (LASSO – Least Absolute Shrinkage and Selection Operator) logistic regression were used to select markers. Results. A significant decrease in relative copy number of mtSSB, MT-RNR2, NRF1, MGME1, and MT-CO1 in plasma was revealed in uterine cancer patients (p 0.005) with a metastatic course of the disease, moreover, the degree of change in copy number increased from G1 to G3. LASSO regression analysis enabled the selection of three genes: mtSSB, MT-RNR2, and MGME1. The combined panel achieved an area under the curve (AUC) of 0.98 (95 % confidence interval 0.96–1.00), a sensitivity of 95 %, and a specificity of 92 % for predicting metastases. Conclusion. Thus, determination of the copy number of the mtSSB, MT-RNR2 and MGME1 genes in blood plasma has potential for use in minimally invasive prediction of metastatic lesions in uterine cancer.
- 18 September 2026
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 13 (3) , 8-19
Open AccessThe genes copy number variation features in blood plasma of uterine cancer patients and disease prognosis
Introduction. Uterine cancer is a leading gynecologic oncology morbidity. Early prediction of metastatic disease is critical for treatment decisions. Therefore, the search for minimally invasive molecular markers for predicting metastasis is a pressing issue. Promising biomarkers in this regard include gene copy number values in circulating cell-free DNA (cfDNA) in plasma. Aim. To analyze the relative copy number of genes regulating mitochondrial function in plasma of uterine cancer patients to develop a minimally invasive method for predicting metastasis. Materials and methods. The bioinformatics phase of the study identified a list of genes associated with mitochondrial dysfunction and abnormal copy number in uterine cancer. The study included 98 patients diagnosed with adenocarcinoma of the corpus uteri (G1 (n = 43), G2 (n = 35) and G3 (n = 20)), 15 patients with uterine myoma and 20 conditionally healthy donors. The relative copy number of 13 genes was determined by quantitative real-time polymerase chain reaction on cfDNA samples from blood plasma. ROC analysis and LASSO-penalized (LASSO – Least Absolute Shrinkage and Selection Operator) logistic regression were used to select markers. Results. A significant decrease in relative copy number of mtSSB, MT-RNR2, NRF1, MGME1, and MT-CO1 in plasma was revealed in uterine cancer patients (p 0.005) with a metastatic course of the disease, moreover, the degree of change in copy number increased from G1 to G3. LASSO regression analysis enabled the selection of three genes: mtSSB, MT-RNR2, and MGME1. The combined panel achieved an area under the curve (AUC) of 0.98 (95 % confidence interval 0.96–1.00), a sensitivity of 95 %, and a specificity of 92 % for predicting metastases. Conclusion. Thus, determination of the copy number of the mtSSB, MT-RNR2 and MGME1 genes in blood plasma has potential for use in minimally invasive prediction of metastatic lesions in uterine cancer.
- Open Access
- 15 September 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (4) , 2630
Antitumor and Antimetastatic Activity of a Novel Pyrimidin-4-one Derivative in the B16–F10 Melanoma Mouse Model: A Pilot Study
Введение. Меланома кожи характеризуется высоким метастатическим потенциалом. Участие EGFR в инвазии и прогрессировании меланомы обосновывает поиск новых EGFR-ориентированных антиметастатических подходов. Цель. Оценка влияния нового производного пиримидин-4-она (6MPSVan-Na) на рост, метастазирование и морфологию перевивной меланомы В16-F10. Материалы и методы. Эксперимент выполнен на самцах мышей C57BL/6 с подкожно трансплантированной меланомой В16–F10. Животные были распределены на три группы (по n = 10 в каждой): основная группа (6MPSVan-Na, 18,7 мг/кг внутримышечно); отрицательный контроль (вода для инъекций внутримышечно); группа гефитиниба (43,4 мг/кг перорально) как позитивный контроль чувствительности модели к ингибиторам тирозинкиназы EGFR. Воздействие проводили в течение пяти дней со дня перевивки, через два дня курс повторяли. Оценивали латентный период, динамику объема и торможения роста опухоли (ТРО %), продолжительность жизни, выживаемость (Kаплан — Майер), частоту макрометастазов. Проведен гистологический анализ опухолевой ткани. Статистическая обработка: критерии Манна — Уитни, точный критерий Фишера, log-rank-тест, ANOVA (уровень значимости α = 0,05). Результаты. Исследование выявило чувствительность меланомы В16-F10 к действию референтного препарат гефитиниба. Профиль противоопухолевой активности экспериментального соединения 6MPSVan-Na характеризовался торможением роста меланомы в постэкспозиционный период (ТРО % ≥ 50 %), статистически значимым увеличением продолжительности жизни мышей, снижением частоты выявления макрометастазов в легких до 20 %, в лимфоузлах — до 30 % (p < 0,05). После воздействия 6MPSVan-Na преимущественно определялись морфологические признаки некроптоза (обширный некроз, выраженная инфильтрация лимфоцитами и гистиоцитами, формирование лимфоцитарного вала и соединительнотканной капсулы). Заключение. В пилотном исследовании новое производное пиримидин-4-она продемонстрировало противоопухолевую и антиметастатическую активность в отношении меланомы В16-F10, реализующуюся, вероятно, через активацию некроптоза и стимуляцию опухолеспецифического иммунного ответа. Полученные данные обосновывают дальнейшее изучение 6MPSVan-Na в качестве потенциального антиметастатического агента при меланоме.
- 15 September 2026
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 72 (4) , 2630
Open AccessAntitumor and Antimetastatic Activity of a Novel Pyrimidin-4-one Derivative in the B16–F10 Melanoma Mouse Model: A Pilot Study
Введение. Меланома кожи характеризуется высоким метастатическим потенциалом. Участие EGFR в инвазии и прогрессировании меланомы обосновывает поиск новых EGFR-ориентированных антиметастатических подходов. Цель. Оценка влияния нового производного пиримидин-4-она (6MPSVan-Na) на рост, метастазирование и морфологию перевивной меланомы В16-F10. Материалы и методы. Эксперимент выполнен на самцах мышей C57BL/6 с подкожно трансплантированной меланомой В16–F10. Животные были распределены на три группы (по n = 10 в каждой): основная группа (6MPSVan-Na, 18,7 мг/кг внутримышечно); отрицательный контроль (вода для инъекций внутримышечно); группа гефитиниба (43,4 мг/кг перорально) как позитивный контроль чувствительности модели к ингибиторам тирозинкиназы EGFR. Воздействие проводили в течение пяти дней со дня перевивки, через два дня курс повторяли. Оценивали латентный период, динамику объема и торможения роста опухоли (ТРО %), продолжительность жизни, выживаемость (Kаплан — Майер), частоту макрометастазов. Проведен гистологический анализ опухолевой ткани. Статистическая обработка: критерии Манна — Уитни, точный критерий Фишера, log-rank-тест, ANOVA (уровень значимости α = 0,05). Результаты. Исследование выявило чувствительность меланомы В16-F10 к действию референтного препарат гефитиниба. Профиль противоопухолевой активности экспериментального соединения 6MPSVan-Na характеризовался торможением роста меланомы в постэкспозиционный период (ТРО % ≥ 50 %), статистически значимым увеличением продолжительности жизни мышей, снижением частоты выявления макрометастазов в легких до 20 %, в лимфоузлах — до 30 % (p < 0,05). После воздействия 6MPSVan-Na преимущественно определялись морфологические признаки некроптоза (обширный некроз, выраженная инфильтрация лимфоцитами и гистиоцитами, формирование лимфоцитарного вала и соединительнотканной капсулы). Заключение. В пилотном исследовании новое производное пиримидин-4-она продемонстрировало противоопухолевую и антиметастатическую активность в отношении меланомы В16-F10, реализующуюся, вероятно, через активацию некроптоза и стимуляцию опухолеспецифического иммунного ответа. Полученные данные обосновывают дальнейшее изучение 6MPSVan-Na в качестве потенциального антиметастатического агента при меланоме.
- Open Access
- 6 September 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (3) , 45-59
Sexual dimorphism of the mitochondrial steroid profile in metastatic rectal cancer
Purpose of the study. To determine the sex-specific features of the content of steroid hormones and their receptors in mitochondria isolated from tumor tissue and the resection line in patients with rectal cancer (RC), depending on the presence or absence of metastases. Patients and methods . The study included 48 patients with RC: 24 men and 24 women. In each group, 12 patients had a localized form (stage T2–3N0M0) and 12 had a metastatic form (stage T2–3N1M0). The groups (men/women, with/without metastases) were comparable in age. The median patient age was 66 (range 58–73) years. Mitochondria were isolated from tumor cells and the resection line of the rectum by differential centrifugation. The levels of estradiol (E2), estrone (E1), free estriol (fE3), testosterone (T), progesterone (P4), cortisol, cholesterol, and receptors (ERα, ERβ, RA, RP4) were determined using ELISA kits (Cusabio, China). Statistical analysis was performed using Statistica 10 software. Results . Opposite sex-dependent changes in the hormonal profile during metastasis were established. In men with metastases, mitochondrial levels of testosterone, cholesterol, and receptors (RA, RP4, ERα) were 1.7–4.5‑fold higher, while free estriol was 1.6‑fold lower. In women, metastases were associated with a 2.5–9.6‑fold decrease in mitochondrial testosterone, ERα, and ERβ levels against a background of a 2.3‑fold increase in free estriol and an 8‑fold increase in cholesterol. In mitochondria from the resection line, the metastatic process partially neutralized the initial sex differences. Conclusion . In metastatic RC, opposite programs of mitochondrial adaptation are activated in men and women. In women, metastasis is associated with a decrease in androgen and estrogen signaling against a background of high estriol, while in men, it is linked to the enhancement of the androgen pathway and synthetic processes. A partial leveling of sex differences in the steroid profile of the resection line is observed, reflecting a systemic metabolic reprogramming that supports an aggressive tumor phenotype. The study findings suggest that mitochondrial biomarkers may have potential for predicting the development of RC; however, further validation in clinical studies is required.
- 6 September 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (3) , 45-59
Open AccessSexual dimorphism of the mitochondrial steroid profile in metastatic rectal cancer
Purpose of the study. To determine the sex-specific features of the content of steroid hormones and their receptors in mitochondria isolated from tumor tissue and the resection line in patients with rectal cancer (RC), depending on the presence or absence of metastases. Patients and methods . The study included 48 patients with RC: 24 men and 24 women. In each group, 12 patients had a localized form (stage T2–3N0M0) and 12 had a metastatic form (stage T2–3N1M0). The groups (men/women, with/without metastases) were comparable in age. The median patient age was 66 (range 58–73) years. Mitochondria were isolated from tumor cells and the resection line of the rectum by differential centrifugation. The levels of estradiol (E2), estrone (E1), free estriol (fE3), testosterone (T), progesterone (P4), cortisol, cholesterol, and receptors (ERα, ERβ, RA, RP4) were determined using ELISA kits (Cusabio, China). Statistical analysis was performed using Statistica 10 software. Results . Opposite sex-dependent changes in the hormonal profile during metastasis were established. In men with metastases, mitochondrial levels of testosterone, cholesterol, and receptors (RA, RP4, ERα) were 1.7–4.5‑fold higher, while free estriol was 1.6‑fold lower. In women, metastases were associated with a 2.5–9.6‑fold decrease in mitochondrial testosterone, ERα, and ERβ levels against a background of a 2.3‑fold increase in free estriol and an 8‑fold increase in cholesterol. In mitochondria from the resection line, the metastatic process partially neutralized the initial sex differences. Conclusion . In metastatic RC, opposite programs of mitochondrial adaptation are activated in men and women. In women, metastasis is associated with a decrease in androgen and estrogen signaling against a background of high estriol, while in men, it is linked to the enhancement of the androgen pathway and synthetic processes. A partial leveling of sex differences in the steroid profile of the resection line is observed, reflecting a systemic metabolic reprogramming that supports an aggressive tumor phenotype. The study findings suggest that mitochondrial biomarkers may have potential for predicting the development of RC; however, further validation in clinical studies is required.
- 21 August 2026
- Published by Publishing House ABV Press in MD-Onco
- Vol. 6 (2) , 57-65
Dynamics of pituitary hormone levels in adolescents with acute lymphoblastic leukemia before and after chemotherapy
Background. Acute lymphoblastic leukemia (ALL) is the most common malignant neoplasm in children. Modern treatment protocols have achieved high survival rates, increasing the significance of investigating early and late therapy-related complications, including endocrine disorders. Dysfunction of the hypothalamic-pituitary axis may develop both during antitumor therapy and prior to its initiation; however, data on the dynamics of pituitary hormone levels in adolescents with ALL remain limited. Aim. To assess blood levels of pituitary hormones – including luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, growth hormone (GH), adrenocorticotropic hormone (ACTH), and thyroid-stimulating hormone (TSH) – in adolescents with ALL before treatment initiation and after completion of therapy. Materials and methods. The study included 40 adolescents of both sexes with ALL (median age 14.55 (11–17) years). The control group consisted of 40 age- and sex-matched apparently healthy children (median age 15.25 (11–17) years). Pituitary hormone levels (LH, FSH, prolactin, GH, ACTH, and TSH) were measured in blood samples before treatment and after the third consolidation phase using standard radioimmunoassay and enzyme-linked immunosorbent assay kits. Mean hormone levels obtained from the control group were used as reference values. Statistical analysis was performed using Statistica 10 software. Results. In girls before treatment, the levels of LH, FSH, and TSH, as well as the LH/FSH ratio, were within the reference range (p 0.05). Prolactin level was elevated 2.9-fold (p 0.05), whereas GH and ACTH levels were reduced 2.5- and 1.8-fold, respectively (p 0.05). After the third consolidation phase, LH and FSH levels increased relative to both the baseline and reference values: LH by factors of 2.1 and 1.6, and FSH by factors of 2.3 and 2.2, respectively (p 0.05). The LH/FSH ratio remained within the reference range. Prolactin level remained elevated, exceeding the reference range by a factor of 2.0 (p 0.05). GH level increased 1.5-fold compared to the baseline (p 0.05) but remained 1.6-fold lower than the reference range (p 0.05). ACTH levels increased 2.1-fold (p 0.05) and reached the reference values. TSH levels remained within the reference range. In boys, LH levels were reduced 1.5-fold before treatment (p 0.05), while FSH levels and the LH/FSH ratio were within the reference range. Prolactin level was elevated 1.8-fold (p 0.05), and GH level was elevated 3.0-fold (p 0.05). ACTH and TSH levels showed 1.7-fold decrease each (p 0.05). After the third consolidation phase, LH levels normalized, increasing 1.6-fold (p 0.05). FSH level increased 1.8-fold relative to the baseline (p 0.05) and remained within the reference range. The LH/FSH ratio remained normal. Prolactin level increased 1.6-fold compared to the baseline (p 0.05) and exceeded the reference range by a factor of 2.9 (p 0.05). GH level decreased 4.3-fold relative to the baseline (p 0.05) and was 1.4-fold below the reference values (p 0.05). ACTH and TSH levels increased by factors of 2.2 and 1.8, respectively (p 0.05), reaching the reference values. Conclusion. ALL in adolescents is associated with dysfunction of the adenohypophysis and an imbalance of tropic hormones, with the direction and magnitude of changes depending on sex and treatment stage. Antitumor therapy rarely results in complete normalization of pituitary hormone levels, which is attributable to both the disease itself and the cytotoxic effects of treatment. These findings support the need for dynamic monitoring of LH, FSH, prolactin, GH, ACTH, and TSH levels in adolescents with ALL at all stages of therapy for early detection and timely correction of endocrine disorders.
- 21 August 2026
- Published by Publishing House ABV Press in MD-Onco
- Vol. 6 (2) , 57-65
Dynamics of pituitary hormone levels in adolescents with acute lymphoblastic leukemia before and after chemotherapy
Background. Acute lymphoblastic leukemia (ALL) is the most common malignant neoplasm in children. Modern treatment protocols have achieved high survival rates, increasing the significance of investigating early and late therapy-related complications, including endocrine disorders. Dysfunction of the hypothalamic-pituitary axis may develop both during antitumor therapy and prior to its initiation; however, data on the dynamics of pituitary hormone levels in adolescents with ALL remain limited. Aim. To assess blood levels of pituitary hormones – including luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, growth hormone (GH), adrenocorticotropic hormone (ACTH), and thyroid-stimulating hormone (TSH) – in adolescents with ALL before treatment initiation and after completion of therapy. Materials and methods. The study included 40 adolescents of both sexes with ALL (median age 14.55 (11–17) years). The control group consisted of 40 age- and sex-matched apparently healthy children (median age 15.25 (11–17) years). Pituitary hormone levels (LH, FSH, prolactin, GH, ACTH, and TSH) were measured in blood samples before treatment and after the third consolidation phase using standard radioimmunoassay and enzyme-linked immunosorbent assay kits. Mean hormone levels obtained from the control group were used as reference values. Statistical analysis was performed using Statistica 10 software. Results. In girls before treatment, the levels of LH, FSH, and TSH, as well as the LH/FSH ratio, were within the reference range (p 0.05). Prolactin level was elevated 2.9-fold (p 0.05), whereas GH and ACTH levels were reduced 2.5- and 1.8-fold, respectively (p 0.05). After the third consolidation phase, LH and FSH levels increased relative to both the baseline and reference values: LH by factors of 2.1 and 1.6, and FSH by factors of 2.3 and 2.2, respectively (p 0.05). The LH/FSH ratio remained within the reference range. Prolactin level remained elevated, exceeding the reference range by a factor of 2.0 (p 0.05). GH level increased 1.5-fold compared to the baseline (p 0.05) but remained 1.6-fold lower than the reference range (p 0.05). ACTH levels increased 2.1-fold (p 0.05) and reached the reference values. TSH levels remained within the reference range. In boys, LH levels were reduced 1.5-fold before treatment (p 0.05), while FSH levels and the LH/FSH ratio were within the reference range. Prolactin level was elevated 1.8-fold (p 0.05), and GH level was elevated 3.0-fold (p 0.05). ACTH and TSH levels showed 1.7-fold decrease each (p 0.05). After the third consolidation phase, LH levels normalized, increasing 1.6-fold (p 0.05). FSH level increased 1.8-fold relative to the baseline (p 0.05) and remained within the reference range. The LH/FSH ratio remained normal. Prolactin level increased 1.6-fold compared to the baseline (p 0.05) and exceeded the reference range by a factor of 2.9 (p 0.05). GH level decreased 4.3-fold relative to the baseline (p 0.05) and was 1.4-fold below the reference values (p 0.05). ACTH and TSH levels increased by factors of 2.2 and 1.8, respectively (p 0.05), reaching the reference values. Conclusion. ALL in adolescents is associated with dysfunction of the adenohypophysis and an imbalance of tropic hormones, with the direction and magnitude of changes depending on sex and treatment stage. Antitumor therapy rarely results in complete normalization of pituitary hormone levels, which is attributable to both the disease itself and the cytotoxic effects of treatment. These findings support the need for dynamic monitoring of LH, FSH, prolactin, GH, ACTH, and TSH levels in adolescents with ALL at all stages of therapy for early detection and timely correction of endocrine disorders.
- Open Access
- 8 August 2026
- Published by Rostov State Medical University in Urology Herald
- Vol. 14 (3) , 48-58
Dynamics of the kallikrein-kinin and renin-angiotensin-aldosterone systems in nephron-sparing surgical treatment of localised renal cell carcinoma
Introduction. Cancer provokes complex systemic responses, including perturbations of the kallikrein-kinin and renin-angiotensin-aldosterone systems. Nephron-sparing surgery for renal cell carcinoma requires a period of ischaemic compression, which predisposes renal parenchyma to ischaemia-reperfusion injury and may precipitate acute kidney injury. Objective. To characterise perioperative changes in components of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients undergoing nephron-sparing surgery for localised renal cell carcinoma. Materials & methods. Perioperative dynamics of kallikrein-kinin and renin-angiotensin-aldosterone system components in plasma and urine were analysed in 46 patients treated surgically for renal cancer. Kallikrein, prekallikrein, total trypsin-like protease activity and carboxypeptidase N activity were measured by chromatographic assays using N-α-benzoyl-L-arginine ethyl ester as substrate. α-1-antitrypsin and α-2-macroglobulin concentrations were determined by ELISA with commercial kits. Renin, angiotensin I, cortisol and aldosterone were quantified by radioimmunoassay. Results. In the early postoperative period following renal resection, surgical trauma and ischaemia-reperfusion provoked a pronounced shift in the protease-inhibitor balance towards proteolysis. Significant alterations were observed across multiple time points. Prekallikrein levels in plasma and urine rose nearly twofold but returned to baseline by postoperative day 3. Activity of kinin-degrading enzymes decreased substantially (approximately 3.5-fold) relative to baseline, whereas total trypsin-like protease activity increased by roughly 1.5-fold. Angiotensin I levels normalised by day 3; aldosterone remained below the normal range, while renin and cortisol were markedly elevated. Conclusion. These findings indicate that renal resection under warm ischaemia triggers early and significant dysregulation of both the kallikrein-kinin and renin-angiotensin-aldosterone systems. A detailed understanding of these pathophysiological changes is crucial for the optimisation of renoprotective strategies and for improving outcomes in patients undergoing nephron-sparing surgery for localised renal cancer.
- 8 August 2026
- Published by Rostov State Medical University in Urology Herald
- Vol. 14 (3) , 48-58
Open AccessDynamics of the kallikrein-kinin and renin-angiotensin-aldosterone systems in nephron-sparing surgical treatment of localised renal cell carcinoma
Introduction. Cancer provokes complex systemic responses, including perturbations of the kallikrein-kinin and renin-angiotensin-aldosterone systems. Nephron-sparing surgery for renal cell carcinoma requires a period of ischaemic compression, which predisposes renal parenchyma to ischaemia-reperfusion injury and may precipitate acute kidney injury. Objective. To characterise perioperative changes in components of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients undergoing nephron-sparing surgery for localised renal cell carcinoma. Materials & methods. Perioperative dynamics of kallikrein-kinin and renin-angiotensin-aldosterone system components in plasma and urine were analysed in 46 patients treated surgically for renal cancer. Kallikrein, prekallikrein, total trypsin-like protease activity and carboxypeptidase N activity were measured by chromatographic assays using N-α-benzoyl-L-arginine ethyl ester as substrate. α-1-antitrypsin and α-2-macroglobulin concentrations were determined by ELISA with commercial kits. Renin, angiotensin I, cortisol and aldosterone were quantified by radioimmunoassay. Results. In the early postoperative period following renal resection, surgical trauma and ischaemia-reperfusion provoked a pronounced shift in the protease-inhibitor balance towards proteolysis. Significant alterations were observed across multiple time points. Prekallikrein levels in plasma and urine rose nearly twofold but returned to baseline by postoperative day 3. Activity of kinin-degrading enzymes decreased substantially (approximately 3.5-fold) relative to baseline, whereas total trypsin-like protease activity increased by roughly 1.5-fold. Angiotensin I levels normalised by day 3; aldosterone remained below the normal range, while renin and cortisol were markedly elevated. Conclusion. These findings indicate that renal resection under warm ischaemia triggers early and significant dysregulation of both the kallikrein-kinin and renin-angiotensin-aldosterone systems. A detailed understanding of these pathophysiological changes is crucial for the optimisation of renoprotective strategies and for improving outcomes in patients undergoing nephron-sparing surgery for localised renal cancer.
- Open Access
- 23 July 2026
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 25 (2) , 38-48
Morphological features of mitochondria isolated from tumor and apparently healthy tissue of the rectum in patients depending on the presence of metastases
Aim. To examine the ultrastructural characteristics of mitochondria isolated from rectal adenocarcinoma tissue and apparently healthy tissue along the tumor resection line in patients of both sexes, depending on the presence or absence of metastases. Materials and methods. The study encompassed the analysis of 28 patients diagnosed with rectal cancer, classified as T2–3N0M0 and T2–3N1–3M1, with tumor differentiation grade G2. Mitochondria were isolated from tumor and intestinal tissue cells via differential centrifugation. The mitochondrial suspension was then placed in a fixative solution containing formaldehyde and glutaraldehyde, followed by immersion in pure Epon-812 resin (SPI Inc., USA). The resin was allowed to cure for a period of 72 hours at a temperature of 70° C. Standard methodologies were employed to prepare the sections, which were then examined using a Jeol JEM-1011 electron microscope (JEOL Inc., Japan). The mitochondrial perimeter on images obtained by electron microscopy was determined using the Fiji program. Results. A comprehensive ultrastructural study and statistical analysis of the perimeter size of mitochondria isolated from rectal adenocarcinoma in patients of both sexes were conducted. The results indicated that there were no statistically significant intergroup differences in mitochondrial size, categorized as conditionally small (0–1 μm), medium (1–2 μm), and large (>2 μm), depending on the presence or absence of metastases. In contrast to the tumor tissue, in apparently healthy tissue along the rectal resection line, the proportion of mitochondria with a perimeter of ˃ 2 μm, characterized by the most pronounced dysfunction, decreased by 3.6 times in women and by 4.8 times in men without metastases compared to the indicators in all patients with metastases ( p < 0.05). Conclusion. The significance of differences in the perimeter dimensions of mitochondria isolated from apparently healthy tissue at the resection line of rectal adenocarcinoma, regardless of gender differences in patients, indicated the possibility of a morphofunctional relationship between processes occurring at the ultrastructural mitochondrial level and metastasis of rectal cancer.
- 23 July 2026
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 25 (2) , 38-48
Open AccessMorphological features of mitochondria isolated from tumor and apparently healthy tissue of the rectum in patients depending on the presence of metastases
Aim. To examine the ultrastructural characteristics of mitochondria isolated from rectal adenocarcinoma tissue and apparently healthy tissue along the tumor resection line in patients of both sexes, depending on the presence or absence of metastases. Materials and methods. The study encompassed the analysis of 28 patients diagnosed with rectal cancer, classified as T2–3N0M0 and T2–3N1–3M1, with tumor differentiation grade G2. Mitochondria were isolated from tumor and intestinal tissue cells via differential centrifugation. The mitochondrial suspension was then placed in a fixative solution containing formaldehyde and glutaraldehyde, followed by immersion in pure Epon-812 resin (SPI Inc., USA). The resin was allowed to cure for a period of 72 hours at a temperature of 70° C. Standard methodologies were employed to prepare the sections, which were then examined using a Jeol JEM-1011 electron microscope (JEOL Inc., Japan). The mitochondrial perimeter on images obtained by electron microscopy was determined using the Fiji program. Results. A comprehensive ultrastructural study and statistical analysis of the perimeter size of mitochondria isolated from rectal adenocarcinoma in patients of both sexes were conducted. The results indicated that there were no statistically significant intergroup differences in mitochondrial size, categorized as conditionally small (0–1 μm), medium (1–2 μm), and large (>2 μm), depending on the presence or absence of metastases. In contrast to the tumor tissue, in apparently healthy tissue along the rectal resection line, the proportion of mitochondria with a perimeter of ˃ 2 μm, characterized by the most pronounced dysfunction, decreased by 3.6 times in women and by 4.8 times in men without metastases compared to the indicators in all patients with metastases ( p < 0.05). Conclusion. The significance of differences in the perimeter dimensions of mitochondria isolated from apparently healthy tissue at the resection line of rectal adenocarcinoma, regardless of gender differences in patients, indicated the possibility of a morphofunctional relationship between processes occurring at the ultrastructural mitochondrial level and metastasis of rectal cancer.
- 23 June 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (2) , 67-78
The copy number variations of genes regulating mitochondrial function in benign and malignant uterine body neoplasms
Purpose of the study. To study changes in the copy number of genes whose products are involved in maintaining the structure and function of mitochondria in tissues of benign neoplasms and endometrioid adenocarcinoma (EA) of the uterine body of varying degrees of differentiation. Materials and methods. The study utilized tumor tissue and normal uterine tissue from 42 patients with endometrioid adenocarcinoma (EA) and 15 patients with uterine fibroids. The tumor burden in the EA patients was between stages Ia and Ib, and neoadjuvant treatment was not administered. DNA was isolated from tumor and normal uterine tissue fragments using phenol-chloroform extraction, and relative gene copy numbers were determined using real-time PCR (real-time qPCR). Statistical analysis was performed using the Mann-Whitney U-test with a Bonferroni correction. Results. In patients with EA G1, a decrease in the copy number of nuclear and mitochondrial genes was observed (MT-CO1 = 0.5, mtTFB = 0.4, mtSSB = 0.6, MT-RNR2 = 0.3, NRF1 = 0.4) (p < 0.005) and an increase in the copy number of MGME1 (2.4) (p < 0.005). In patients with EA G2, a picture similar to G1 is observed: a decrease in the copy number of the genes MT-CO1; mtTFB, MT-RNR2 and NRF1 (p < 0.005), except for mtSSB. An increase in the copy number of MGME1 (3.1) and POLRMT (1.8) (p < 0.005) was also recorded. In patients with EA G3, the most pronounced decrease in the copy number of mtSSB and MT-RNR2 by 5.0 times relative to normal tissue was found, as well as a decrease in the copy number of MGME1 by 3.3 times, which is the opposite of the results in G1/G2. Conclusion. Significant differences in the copy number of genes involved in mitochondrial function were identified between benign uterine tissues and endometrioid adenocarcinoma. The most prominent alterations included reduced copy numbers of key mitochondrial genes (MT-CO1 and MT-RNR2), the nuclear gene mtSSB, and aberrant MGME1 copy number changes in tumor tissues. These findings provide new insights into the molecular mechanisms underlying endometrioid adenocarcinoma development and may contribute to the identification of potential diagnostic and prognostic biomarkers.
- 23 June 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (2) , 67-78
The copy number variations of genes regulating mitochondrial function in benign and malignant uterine body neoplasms
Purpose of the study. To study changes in the copy number of genes whose products are involved in maintaining the structure and function of mitochondria in tissues of benign neoplasms and endometrioid adenocarcinoma (EA) of the uterine body of varying degrees of differentiation. Materials and methods. The study utilized tumor tissue and normal uterine tissue from 42 patients with endometrioid adenocarcinoma (EA) and 15 patients with uterine fibroids. The tumor burden in the EA patients was between stages Ia and Ib, and neoadjuvant treatment was not administered. DNA was isolated from tumor and normal uterine tissue fragments using phenol-chloroform extraction, and relative gene copy numbers were determined using real-time PCR (real-time qPCR). Statistical analysis was performed using the Mann-Whitney U-test with a Bonferroni correction. Results. In patients with EA G1, a decrease in the copy number of nuclear and mitochondrial genes was observed (MT-CO1 = 0.5, mtTFB = 0.4, mtSSB = 0.6, MT-RNR2 = 0.3, NRF1 = 0.4) (p < 0.005) and an increase in the copy number of MGME1 (2.4) (p < 0.005). In patients with EA G2, a picture similar to G1 is observed: a decrease in the copy number of the genes MT-CO1; mtTFB, MT-RNR2 and NRF1 (p < 0.005), except for mtSSB. An increase in the copy number of MGME1 (3.1) and POLRMT (1.8) (p < 0.005) was also recorded. In patients with EA G3, the most pronounced decrease in the copy number of mtSSB and MT-RNR2 by 5.0 times relative to normal tissue was found, as well as a decrease in the copy number of MGME1 by 3.3 times, which is the opposite of the results in G1/G2. Conclusion. Significant differences in the copy number of genes involved in mitochondrial function were identified between benign uterine tissues and endometrioid adenocarcinoma. The most prominent alterations included reduced copy numbers of key mitochondrial genes (MT-CO1 and MT-RNR2), the nuclear gene mtSSB, and aberrant MGME1 copy number changes in tumor tissues. These findings provide new insights into the molecular mechanisms underlying endometrioid adenocarcinoma development and may contribute to the identification of potential diagnostic and prognostic biomarkers.